RecallHawk

BILPREVDA (DENOSUMAB)

SHANGHAI HENLIUS BIOTECH

Summary

FDA approved BILPREVDA (DENOSUMAB) by SHANGHAI HENLIUS BIOTECH. BLA (Biologic) approval (Efficacy) on 2025-10-29. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

BLA761444-2

Action Date

2025-10-29

Status

Approved

Category

drug

Product Code

BLA (Biologic)

Product Description

BILPREVDA (generic: DENOSUMAB), INJECTABLE, INJECTION. Application: BLA761444

Context & Analysis

SHANGHAI HENLIUS BIOTECH has 2 FDA actions in our database.

Frequently Asked Questions

How often does SHANGHAI HENLIUS BIOTECH have FDA actions?

SHANGHAI HENLIUS BIOTECH has 2 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "BLA761444-2" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions